CMC Asset Lead, Nephrology
Biogen · Cambridge, MA +2 more
RoleLantern re-checked this role's application link recently and it was active — the employer has not confirmed it directly.
Role summary
This role leads chemistry, manufacturing, and controls (CMC) strategy for a nephrology asset in late-stage clinical development, overseeing launch planning and lifecycle management through 2028–2030. The successful candidate will develop multi-year asset strategies, manage cross-functional teams, handle financial accountability, and influence key business decisions across the organization. The position requires 12+ years in matrix management, CMC expertise spanning IND to approval, and proven commercial launch experience.
Privacy & handoff
This role links to Biogen's own application system. RoleLantern records your interest and checks the link, but the application happens on the employer's site and status updates may not come back to us. Clicking apply does not mark you as applied automatically.